Amgen's Breakaway from Cancer® Public Service Announcement Delivers Message That Education, Resources And Hope Are Essential In The Fight Against Cancer Read more about Amgen's Breakaway from Cancer® Public Service Announcement Delivers Message That Education, Resources And Hope Are Essential In The Fight Against Cancer
Amgen Commences Exchange Offers for Certain Series of Outstanding Senior Notes from Exchange Eligible Holders Read more about Amgen Commences Exchange Offers for Certain Series of Outstanding Senior Notes from Exchange Eligible Holders
Hall of Fame Quarterback Joe Montana and Amgen Team Up to Launch Breakaway from Heart Disease™ to Make Heart Health a Priority Read more about Hall of Fame Quarterback Joe Montana and Amgen Team Up to Launch Breakaway from Heart Disease™ to Make Heart Health a Priority
Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral Read more about Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral
Amgen To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference Read more about Amgen To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For BLINCYTO® (Blinatumomab) Read more about FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For BLINCYTO® (Blinatumomab)
Amgen's First Quarter 2016 Revenues Increased 10 Percent To $5.5 Billion And Adjusted Earnings Per Share (EPS) Increased 17 Percent To $2.90 Read more about Amgen's First Quarter 2016 Revenues Increased 10 Percent To $5.5 Billion And Adjusted Earnings Per Share (EPS) Increased 17 Percent To $2.90
Amgen Announces Webcast Of 2016 First Quarter Financial Results Read more about Amgen Announces Webcast Of 2016 First Quarter Financial Results
Amgen To Participate In The 2016 World Medical Innovation Forum™ On Cancer Read more about Amgen To Participate In The 2016 World Medical Innovation Forum™ On Cancer
Nplate® (Romiplostim) Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia Read more about Nplate® (Romiplostim) Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia
